Circulation · 2004 · 94 citations · 18 references
MedicineCardiologySurgeryCardiovascular PharmacotherapyClinical CardiologyInterventional CardiologyAntithrombotic TherapyCoronary Artery DiseaseIschemic Heart DiseasePercutaneous Coronary InterventionStent PlacementThrombosisAntithrombotic Therapy After Stent ImplantationComplications Of Stent PlacementCoronary StentingExact Logistic RegressionGlycoprotein Iib FunctionGlycoprotein Iiia FunctionLogistic Regression
BACKGROUND: Intraprocedural stent thrombosis (IPST) is a rare event (<0.01% in our experience with bare metal stents), with the exception of specific settings such as acute myocardial infarction, thrombus-containing lesions, and dissections. We report the occurrence of this event during elective implantation of sirolimus-eluting stents. METHODS AND RESULTS: Between April 2002 and August 2003, 670 patients with 1362 lesions were treated with Cypher (Cordis, Johnson and Johnson Co) sirolimus-eluting stent implantation in San Raffaele Hospital and EMO Centro Cuore Columbus. Diabetes mellitus was present in 142 patients (21%), and 164 (24.5%) had unstable angina. Pretreatment with glycoprotein IIb/IIIa (GP IIb/IIIa) inhibitors was carried out in 235 patients (35%). Total stent length per vessel was 42.9+/-28.3 mm. IPST occurred in 5 patients (0.7%). None of the patients with IPST were pretreated with GP IIb/IIIa inhibitors. Using univariate exact logistic regression, only total stent length per vessel, in millimeters (exact OR, 1.03; 95% CI, 1.011 to 1.046; P=0.0028), was associated with the occurrence of IPST. CONCLUSIONS: Stent length was associated with the occurrence of IPST. Particular attention will need to be directed to this potential complication when long sirolimus-eluting stents are being used.
18
Thomas J. Ryan, David P. Faxon, R M Gunnar et al. · Circulation · 1988 · 2.1K citations · Full text
Sam Ellis, Michel Vandormael, Michael J. Cowley et al. · Circulation · 1990 · 1.3K citations
Medicine, Cardiology, Surgery +17